M Elwan Ayman, Naroz Mohamed, Abdelrahman Eid Mohamed Eid, Abo Elkher Mohamed Elsaed, Hefny Abd-Alhamed, El-Syed Ibrahim Masoud Kh, Abdelsattar Ebrahim Lotfy, Gaber Bakheet Mohmed Bakheet, Mahmoud Hussein Ahmed, Helmy Elsaied Hussein Mahmoud
Department of General Surgery, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Department of General Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egyp.
Med J Islam Repub Iran. 2023 Nov 13;37:121. doi: 10.47176/mjiri.37.121. eCollection 2023.
Recently, obesity witnessed a dramatic increase and its related comorbidities have grown. Bariatric surgeries were developed to reduce weight. However, all techniques had their advantages and shortages. In this work, we aimed to assess our new modification of combining sleeve gastrectomy with Roux en-y bypass for the management of obesity, hoping to gain benefits from both techniques to increase the excess bodyweight loss (EBW%).
The study was a prospective observational study on 23 Morbidly obese patients. The study was held from January 2020 to April 2022. The recruited patients were submitted to detailed clinical assessment and investigations to check fitness for surgery. Besides operative data, any intra- or post-operative complications were recorded. Each patient was followed up for at least one year. The follow-up visits were scheduled at regular intervals (one week, one month, six months, and twelve months).
The mean operative time was 113.91 minutes (65-150). No intraoperative complications or conversion. There was intraluminal bleeding in one patient within 48 hours postoperatively with successful conservative management. There was a complete cure of diabetes mellitus (DM) for 5, 2, and 3 patients and antidiabetic drugs were reduced for 64.3%, 21.43%, and 7.14% at 1, 6, and 12 months follow up respectively. Hypertension was cured in 1,1,2 patients, and antihypertensives were reduced for 2,1,1 patient, at 1, 6, and 12 months follow up respectively. EWL% was 14.4%, 40.78%, and 73.74% at 1,6,12 months follow up respectively. Hemoglobin concentration and ionized calcium improved over time. Finally, serum albumin at 1, 6, and 12 months follow-up was 3.64, 3.58, 3.78 g/dL respectively.
New modifications of combining LSG and LRYGB have shown to be safe and effective procedures. In addition, it is associated with minimal postoperative nutritional complications and permits complete visualization of the biliary system using endoscopy.
近年来,肥胖率急剧上升,与之相关的合并症也不断增加。减重手术应运而生以减轻体重。然而,所有技术都各有优缺点。在本研究中,我们旨在评估袖状胃切除术与Roux-en-Y胃旁路术联合的新改良术式用于肥胖治疗的效果,希望从两种技术中获益以提高超重体重减轻率(EBW%)。
本研究是一项针对23例病态肥胖患者的前瞻性观察研究。研究于2020年1月至2022年4月进行。招募的患者接受了详细的临床评估和检查以确定手术适应性。除手术数据外,还记录了任何术中或术后并发症。每位患者至少随访一年。随访安排在定期(一周、一个月、六个月和十二个月)进行。
平均手术时间为113.91分钟(65 - 150分钟)。无术中并发症或中转情况。1例患者术后48小时内出现腔内出血,但保守治疗成功。在1、6和12个月随访时,分别有5例、2例和3例患者的糖尿病完全治愈,64.3%、21.43%和7.14%的患者抗糖尿病药物用量减少。在1、6和12个月随访时,分别有1例、1例和2例患者的高血压治愈,2例、1例和1例患者的抗高血压药物用量减少。在1、6和12个月随访时,EWL%分别为14.4%、40.78%和73.74%。血红蛋白浓度和离子钙随时间改善。最后,在1、6和12个月随访时血清白蛋白分别为3.64、3.58、3.78 g/dL。
袖状胃切除术(LSG)与Roux-en-Y胃旁路术(LRYGB)联合的新改良术式已被证明是安全有效的手术。此外,它与术后最小的营养并发症相关,并且允许使用内镜完全观察胆道系统。